Home Medical stocks 5 Peter Lynch Growth Stocks to Consider for 2nd Quarter

5 Peter Lynch Growth Stocks to Consider for 2nd Quarter

42
0

According to the Peter Lynch Growth Screen, a Premium All-in-One Screener template, five stocks with high financial strength, good revenue growth and are trading below the Peter Lynch earnings line as of Tuesday are Big Lots Inc. (NYSE:BIG), The Cooper Companies Inc. (NYSE:COO), Emergent BioSolutions Inc. (NYSE:EBS), SPAR Group Inc. (NASDAQ:SGRP) and Worthington Industries Inc. (NYSE:WOR).

Lynch, who managed the Fidelity Magellan Fund during the 1980s, wrote in his book “One Up on Wall Street” that one can quickly measure a stock’s valuation by comparing the stock’s price to a fair value at 15 times earnings. A stock is undervalued if it trades below a price-earnings ratio of 15.

07ab4e2b94ea679b2c39407a91ed8214.png

GuruFocus’ Peter Lynch Growth Screen also looks for stocks with 10-year revenue growth of at least 6% and a business predictability rank of at least two stars out of five. To further narrow the list of companies to high-quality stocks, one can require a financial strength rank of at least 6.

The Screener listed five companies meeting the above criteria as of Tuesday.

Big Lots

Shares of Big Lots (NYSE:BIG) traded around $69.65, approximately 4.38 times its earnings per share. The stock’s price-earnings ratio outperforms over 98% of global competitors.

bb869d344aae882c2dce5a394570e7d0.png

GuruFocus ranks the Columbus-based discount retailer’s profitability 7 out of 10 on several positive investing signs, which include a high Piotroski F-score of 7, a three-year revenue growth rate that outperforms over 73% of global competitors and an operating margin that tops more than 80% of global defensive retail companies.

eaf5ed0d59ac3e555c5459366aadf570.png

Big Lots’ financial strength ranks 6 out of 10 on the back of a high Altman Z-score of 4.11 and debt ratios outperforming over 66% of global competitors. Gurus with large holdings in Big Lots include Pioneer Investments (Trades, Portfolio) and Jeremy Grantham (Trades, Portfolio)’s GMO.

135c73ba3a34edfff603ce7bb8170c46.png

The Cooper Companies

Shares of The Cooper Companies (NYSE:COO) traded around $388.98, approximately 8.98 times its earnings per share. The company’s price-earnings ratio is near a 10-year low and outperforms more than 91% of global medical device companies.

c84705d4e181df47f9e8864d03033f35.png

GuruFocus ranks the San Ramon, California-based medical company’s financial strength 6 out of 10 on the back of a strong Altman Z-score of 5.19 despite debt ratios underperforming over 60% of global competitors.

2fbd2cf20a9a29c14a3fc04f5db6ccd5.png

Cooper’s profitability ranks 8 out of 10 on several positive investing signs, which include expanding operating margins and a five-star business predictability rank.

41e9e088eb020000b6131cae1b1257ca.png

Emergent BioSolutions

Shares of Emergent BioSolutions (NYSE:EBS) traded around $79.25, approximately 14 times its earnings per share. Despite this, the stock’s price-earnings ratio is near a five-year low; further, the stock is significantly undervalued based on Tuesday’s price-to-GF Value ratio of 0.66.

48f42ef2a037ea1b22d96f3c7be57007.png

GuruFocus ranks the Gaithersburg, Maryland-based drug manufacturer’s profitability 8 out of 10 on several positive investing signs, which include a three-star business predictability rank, a high Piotroski F-score of 7 and profit margins and returns outperforming over 88% of global competitors.

08a45f1f16fe3a62c2c53117dbe5e0d6.png

Emergent BioSolutions’ financial strength ranks 6 out of 10 on the heels of a strong Altman Z-score of 3.48 despite debt ratios underperforming more than 60% of global competitors.

d57a266d055370c520e81f2239057219.png

SPAR Group

Shares of SPAR Group (NASDAQ:SGRP) traded around $1.65, approximately 10.66 times its earnings per share.

9dd672a6603f8870710f5bfea6a54304.png

GuruFocus ranks the White Plains, New York-based merchandising and marketing company’s profitability 8 out of 10 on several positive investing signs, which include a high Piotroski F-score of 8, a three-star business predictability rank and an operating margin that has increased approximately 13.8% per year on average over the past five years.

02210cf7ddf0306b40acbda3a512ad3c.png

SPAR Group’s financial strength ranks 6 out of 10 on the back of debt-to-Ebitda ratios outperforming over 60% of global competitors.

3f432c03a981e7f2a74bef149831cbb5.png

Worthington Industries

Shares of Worthington Industries (NYSE:WOR) traded around $68.90, approximately 6.05 times its earnings per share. The company’s price-earnings ratio outperforms over 96% of global competitors.

22922d7029a4c2306e002f13c35837b6.png

GuruFocus ranks the Columbus-based manufacturing company’s profitability 7 out of 10 on the back of a high Piotroski F-score of 7 and returns outperforming over 98% of global competitors despite operating margins topping just over half of global industrial companies.

7f62291edd5176402ce3a1f6cf323829.png

Worthington’s financial strength ranks 6 out of 10 due to a strong Altman Z-score of 3.44 and a debt-to-Ebitda ratio that outperforms more than 70% of global competitors.

dc77675a596b182a8c8c8081c1ea15d8.png

Disclosure: The author has no positions in the stocks mentioned. The mention of stocks in this article do not constitute a recommendation. Investors must do their own diligent research before investing in the stock market.

Different valuation methods may produce different valuation zones: A stock may be undervalued based on the Peter Lynch earnings line yet overvalued based on its price-sales ratio or our exclusive GF Value method.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

https://www.gurufocus.com/news/1393230/5-peter-lynch-growth-stocks-to-consider-for-2nd-quarter
https://www.gurufocus.com/news/1393230/5-peter-lynch-growth-stocks-to-consider-for-2nd-quarter

This site uses Akismet to reduce spam. Learn how your comment data is processed.